EGFR and lung adenocarcinoma: In conclusion, our study demonstrated that platelets in the high D-dimer plasma were activated and induced EGFR TKI resistance through Src-mediated EGFR transactivation, Akt activation, and EMT in patients with mutant lung adenocarcinoma.